| 标题 |
Updated Results of Talquetamab, a GPRC5D×CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma with Prior Exposure to T-Cell Redirecting Therapies: Results of the Phase 1/2 MonumenTAL-1 Study |
| 网址 | |
| DOI |
10.1182/blood-2023-187242
doi
|
| 其它 |
期刊:Blood 作者:Andrzej J Jakubowiak; Sebastien Anguille; Lionel Karlin; Ajai Chari; Carolina Schinke; et al 出版日期:2023-12-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)